CellSource Co., Ltd.
Status: Publicly traded
Direct answer
CellSource Co., Ltd. is publicly traded on JPX under the ticker 4880.T.
CellSource Co., Ltd. operates within both the regenerative medicine and consumer product sectors. Among its offerings is Signalift, an anti-aging solution. The company, which was established in 2015, is headquartered in Tokyo, Japan.
Can you invest in CellSource Co., Ltd.?
Yes. CellSource Co., Ltd. trades publicly on JPX as 4880.T.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for CellSource Co., Ltd.
Detailed equity research is provided by MarketSnap.